A systematic review of interleukin-31 inhibitors in the treatment of prurigo nodularis

ConclusionsIL-31 inhibitors suggest distinct advantages in improving pruritus, sleep quality, and overall quality of life in subjects with moderate-to-severe PN. Further clinical studies are recommended to compare the effectiveness of these biologics to other therapeutic choices.
Source: Inflammopharmacology - Category: Drugs & Pharmacology Source Type: research